Abstract
Microscopic residual tumor (R1) affects prognosis of resected pancreatic head cancer patients. Surgeon’s ability, caseload and accuracy of pathological staging affect the rate of R1 resections. The goal of this study was to verify if a standardized histopathological workup of the specimen affects the rate of microscopic residual tumor after PD for cancer. Two groups of specimens were managed with (Group 1, Standardized Group, SG) or without (Group 2, Non Standardized Group, NSG) a standardized histopathological workup reported by the Royal College of Pathologists. Group 1 included 50 cases of PD for periampullary cancer treated between October 2010 and July 2012. Group 2 included 50 cases of PD for periampullary cancer treated between September 2005 and September 2010. The primary endpoint of the study was to verify the differences in terms of R1 rate in the two groups. Correlation between presence/absence of microscopic residual tumor status and local recurrence was also evaluated. The cohort of 100 patients consisted of 66 pancreatic ductal adenocarcinoma (PDAC) (SG: 35; NSG: 31), 15 distal common bile duct cancer (SG: 9; NSG: 6) and 19 cancer of the ampulla of Vater (SG: 6; NSG: 13). The rate of R1 resections resulted higher in the SG (66% vs 10%, p < 0.05). The rate of local recurrence did not differ in the two groups (NSG 23.4%, SG 27.6%). No relationships were found between R1 status and development of local recurrence in both groups. Local recurrence occurred in 20% of R1-NSG and in 34.3% of R1-SG. Our study showed that the standardized method determines a significant increase of R1 resection if compared with other non-standardized methods. This difference is due to the different definition of minimum clearance (0-mm- vs 1-mm rule). Even if not significantly, the standardized method seems to better discriminate the patients in terms of local recurrence risk after R1 vs R0 in SG (34 vs 11%) in comparison with R1 vs R0 in NSG (20 vs 27%).
Similar content being viewed by others
References
Chandrasegaram MD, Goldstein D, Simes J et al (2015) Meta-analysis of radical resection rates and margin assessment in pancreatic cancer. Br J Surg 102:1459–1472
Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P et al (2001) European Study Group for Pancreatic Cancer. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234:758–768
Matsuno S, Egawa S, Unno M (2007) R0 resection for ductal pancreatic cancer—Japanese experience. Am J Surg 194:S110–S114
Hruban RH et al (2010) WHO classification of Tumours of Digestive System, Fourth Edition. ISBN-13 9789283224327
Evans DB, Farnell MB et al (2009) Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 16:1736–1744
Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, Gutberlet K, Kettner E, Schmalenberg H, Weigang-Koehler K, Bechstein WO, Niedergethmann M, Schmidts-Wolf I, Roll L, Doerken B, Riess H (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277
Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M (2003) Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 27:324–329
Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW (2004) Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91:586–594
Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S (2006) Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 10:511–518
Sperti C, Pasquali C, Piccoli A, Pedrazzoli S (1997) Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 21:195–200
Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH et al (2007) Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246:52–60
Butturini G, Stocken DD, Wente MN, Jeekel H, Klinkbijl JHG, Bakkevold K et al (2008) Influence of resection margins and treatment on survival in patients with pancreatic cancer. Meta-analysis of randomized controlled trials. Arch Surg 143:75–83
Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I (1993) An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 71:2118–2223
Westerdahl J, Andren-Sandberg A, Ihse I (1993) Recurrence of exocrine pancreatic cancer: local or hepatic? Hepatogastroenterology 40:384–387
Butler J, Ahmad S, Katz M, Cioffi J, Zyromski N (2016) A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreaticoduodenectomy for pancreatic adenocarcinoma. HPB 18:305–311
Rau Bettina et al (2012) R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use. Surgery 152(3 Suppl 1):S103–S111
Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A (2006) Redefining the R1 resection in pancreatic cancer. Br J Surg 93:1232–1237
Esposito I, Kleef J, Friess H (2007) Surgical treatment of pancreatic cancer. J Am Coll Surg 205:S81–S86
Menon KV, Gomez D, Smith AM, Anthoney A, Verbeke CS (2009) Impact of margin status on survival following pancreaticoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP). HPB 11:18–24
Michalski CW, Kleff J, Wente MN et al (2007) Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg 94:265–273
The Royal College of Pathologists (2002) Standards and minimum datasets for reporting cancers. Minimum dataset for the histopathological reporting of pancreatic, ampulla of Vater and bile duct carcinoma. The Royal College of Pathologists, London
Rosai J (2004) Appendix E. Rosai and Ackerman’s surgical pathology, 9th edn. Mosby, Edinburgh, pp 2953–Y2954
Cox DR (1972) Regression models and life-tables. J Roy Stat Soc B 34(2):187–220
Verbeke CS (2008) Resection margins and R1 rates in pancreatic cancer—are we there yet? Histopathology 52:787–796
Liszka L, Pajak J, Zielinska-Pajak E, Golka D, Mrowiec S, Lampe P (2010) Different approaches to assessment of lymph nodes and surgical margin status in patients with ductal adenocarcinoma of the pancreas treated with pancreaticoduodenectomy. Pathology 42:138–146
Khalifa MA, Maksymov V, Rowsell CH, Hanna S (2007) A novel approach to the intraoperative assessment of the uncinate margin of the pancreaticoduodenectomy specimen. HPB 9:146–149
Compton CC, Henson DE (1997) Protocol for the examination of specimens removed from patients with carcinoma of the exocrine pancreas; a basis for checklists. Cancer Committee, College of American Pathologists. Arch Pathol Lab Med 121:1129–1136
Luttges J, Vogel I, Menke M, Henne-Bruns D, Kremer B, Kloppel G (1998) The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Virchows Arch 433:237–242
Washington K et al (2013) Protocol for the examination of specimens from patients with carcinoma of the exocrine pancreas. College of American Pathologists. Based on AJCC/UICC TNM, 7th edition
Campbell Dr F et al (2010) Dataset for the histopathological reporting of carcinomas of the pancreas, ampulla of Vater and common bile duct. The Royal College of Pathologists
Capella et al (2011) Carcinoma of the exocrine pancreas: the histology report. Dig Liver Dis 43S:S282–S292
Verbeke CS, Gladhaug IP (2012) Resection margin involvement and tumour origin in pancreatic head cancer. Br J Surg 99:1036–1049
Verbeke CS, Menon KV (2009) Redefining resection margin status in pancreatic cancer. HPB 11:282–289
Campbell F, Smith RA, Whelan P, Sutton R, Raraty M, Neoptolemos JP et al (2009) Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin. Histopathology 55:277–283
Gaedcke J, Gunawan B, Grade M, Szoke R, Liersch T, Becker H et al (2010) The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials. Lagenbecks Arch Surg 395:451–458
Schlitter AM, Esposito I (2010) Definition of microscopic tumour clearance (R0) in pancreatic cancer resections. Cancers 2:2001–2010
Albores-Saavedra J, Heffess C, Hruban RH, Klimstra D, Longnecker D (1999) Recommendations for the reporting of pancreatic specimens containing malignant tumours. The Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol 11:304–307
Chatelain D, Flejou JF (2002) Pancreatectomy for adenocarcinoma: prognostic factors, recommendations for pathological reports. Ann Pathol 22:422–431
Hruban RH, Pitman MB, Klimstra DS (2007) Tumors of the pancreas. Atlas of tumor pathology 4th Series, Fascicle 6. Armed Forces Institute of Pathology, Washington
Khalifa MA (2007) Intraoperative assessment of the Whipple resection specimen. J Clin Pathol 60:975–980
Nagtegaal ID, Corrie A, Marijen M, Kranenbarg EK, van de Velde CJH, van Krieken JHJM (2002) Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma. Not 1 mm but 2 mm is the limit. Am J Surg Pathol 26:350–357
Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE et al (2002) Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 89:327–334
Osipov A, Naziri J, Hendifar A et al (2015) Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: implications for adjuvant radiotherapy. J Gastrointest Oncol 7:239–247
Howard TJ, Krug JE, Yu J, Zyromski NJ, Schmidt CM, Jacobson LE et al (2006) A margin negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to longterm survival in pancreatic cancer. J Gastrointest Surg 10:1338–1345
Westgard A, Tafjord S, Farstaid IN, Cvancarova M, Eide TJ, Mathisen O et al (2008) Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol 35:600–604
Ferrone CR, Pieretti-Vanmarcke R, Bloom JP, Zheng H, Szymonifka J, Wargo JA et al (2012) Pancreatic ductal adenocarcinoma: longterm survival does not equal cure. Surgery 152(Suppl.):43–49
Fatima J, Schnelldorfer T, Barton J, Wood CM, Wiste JH, Smryk TC et al (2010) Pancreaticoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival. Arch Surg 145:165–172
Hartwing W, Hackert T, Hinz U, Gluth A, Bergmann F, Strobel O et al (2011) Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg 254:311–319
Buchler MW, Werner J, Weitz J (2010) R0 in pancreatic cancer: surgery, pathology, biology, or definition matters? Ann Surg 251:1011–1012
Jamieson NB, Denley SM, Logue J, MacKenzie DJ, Foulis AK, Dickson EJ et al (2011) A prospective comparison of the prognostic value of tumour and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma. Ann Surg Oncol 18:2318–2328
Van der Broeck A, Sergeant G, Ectors N, Van Steenbergen W, Aerts R, Topal B (2009) Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol 35:600–604
Rau BM, Moritz K, Schuschan S, Alsfasser G, Prall F, Klar E (2012) R1 resection in pancreatic cancer has significant impact on longterm outcome in standardized pathology modified for routine use. Surgery 152(Suppl.):103–111
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Research involving human participants and/or animals
The article does not contain any research with human participants performed by the authors.
Informed consent
For this type of study formal consent is not required.
Rights and permissions
About this article
Cite this article
Coppola, R., Cartillone, M., Borzomati, D. et al. Surgical margins for duodenopancreatectomy. Updates Surg 68, 279–285 (2016). https://doi.org/10.1007/s13304-016-0404-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13304-016-0404-x